Back to results
US 2022/0175762 A1Published application
Immune modulatory compositions and methods for treating cancers
AssigneeBirdie Biopharmaceuticals, Inc.
InventorLixin Li
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to immune modulatory compositions and methods for treating cancers using combination therapy.
Claims35
A combination, comprising:
- (i) an effective amount of an immune modulatory chemotherapeutic;
- and
- (ii) an effective amount of immunotherapeutic comprising a TLR7 and/or TLR8 agonist activity.
Dependencies are inferred from the claim text.